Pay in 4 interest-free payments of $6.33 Learn more
Ships within 48 hours · Estimated delivery Aug 23 - Aug 28
Less than 1% of people with B12 deficiency report getting optic neuropathy
Is BPC-157 + TB-500 FDA-approved
As noted, the present knowledge is limited, and these are considerations, not strong recommendations
For TB-500, the foundational cardiac research by Bock-Marquette et al
Most people dont have problems with B12 shots, but some might feel pain or redness at the site, have diarrhea, or itch
Injectable GHK-Cu was in Category 2 the more restrictive category for substances with "significant safety concerns." Its removal from Category 2 is the more positive development, as it signals the FDA no longer considers injectable GHK-Cu to carry the safety risk level that warranted Category 2 placement
